AT-1501
AT-1501-N205
Phase 2 small_molecule terminated
Quick answer
AT-1501 for IgA Nephropathy is a Phase 2 program (small_molecule) at Eledon Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eledon Pharmaceuticals
- Indication
- IgA Nephropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated